Table 3:
Variation accounted for by fructose, glucose or their combination on measured outcomes
| Total variation accounted for in % [95% CI] |
P-value | |
|---|---|---|
| Fasting nonHDL-C | ||
| F | 4.97% [0.4% to 11.3%] | 0.002 |
| G | 0.75% [0.0% to 5.9%] | 0.209 |
| F*G | 5.86% [0.7% to 14.6%] | 0.002 |
| Postprandial nonHDL-C | ||
| F | 11.20% [10.6% to 21.3%] | <0.0001 |
| G | 1.58% [1.1% to 7.7%] | 0.062 |
| F*G | 5.39% [4.9% to 13.9%] | 0.002 |
| Fasting LDL-C | ||
| F | 5.84% [0.7% to 14.5%] | 0.001 |
| G | 0.08% [0.0% to 3.3%] | 0.661 |
| F*G | 6.17% [0.8% to 15.0%] | 0.001 |
| Postprandial LDL-C | ||
| F | 4.01% [0.1% to 11.9%] | 0.006 |
| G | 0.46% [0.0% to 5.0%] | 0.306 |
| F*G | 8.43% [1.8% to 18.0%] | 0.0002 |
| Fasting apoB | ||
| F | 4.44% [0.2% to 5.6%] | 0.004 |
| G | 0.34% [0.0% to 0.5%] | 0.396 |
| F*G | 4.51% [0.3% to 12.6%] | 0.005 |
| Postprandial apoB | ||
| F | 6.64% [1.0% to 15.6%] | 0.001 |
| G | 1.37% [0.0% to 7.3%] | 0.099 |
| F*G | 5.21% [0.4% to 13.7%] | 0.003 |
| 24-h TG AUC | ||
| F | 10.90% [3.1% to 21.0%] | <0.0001 |
| G | 2.30% [0.0% to 9.1%] | 0.049 |
| F*G | 0.42% [0.0% to 4.9%] | 0.340 |
| Postprandial apoCIII | ||
| F | 11.67% [3.6% to 21.9%] | <.0001 |
| G | 1.94% [0.0% to 8.4%] | 0.064 |
| F*G | 0.03% [0.0% to 2.5%] | 0.8099 |
| 24-h uric acid AUC | ||
| F | 32.72% [20.6% to 43.3%] | <.0001 |
| G | 4.82% [0.3% to 13.1%] | 0.001 |
| F*G | 0.00% [0.0% to 0.8%] | 0.943 |
| Fasting ox.LDLa | ||
| F | 0.57% [0.0% to 6.5%] | 0.384 |
| G | 0.45% [0.0% to 6.1%] | 0.538 |
| F*G | 15.26% [4.7% to 27.6%] | <0.0001 |
Data were estimated from Mulivariate regression model (fructose, glucose, fructose*glucose) adjusted for outcome at Baseline and sex
F- fructose, G – glucose